IP Library › Granted Patent US 11,365,203
Granted Patent B2
US 11,365,203 · App. 16/318,762 · Granted Jun 21, 2022

Fluorescent dye and preparation method and use thereof

Inventors: Linyong Zhu (Shanghai, CN); Yi Yang (Shanghai, CN); Dasheng Zhang (Shanghai, CN); Zengmin Du (Shanghai, CN); Bingkun Bao (Shanghai, CN); Qiuning Lin (Shanghai, CN); Yan Li (Shanghai, CN); Xianjun Chen (Shanghai, CN); Lipeng Yang (Shanghai, CN); Chunyan Bao (Shanghai, CN)
Assignee: FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY LTD.
C07D495/04A61K49/00C07D333/60C07D333/78C07D495/14C09B23/0058C09B23/0091C09B23/04C09B57/00C09K11/06C12Q1/68G01N33/533G01N33/68
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,365,203
App. No.
16/318,762
Granted
Jun 21, 2022
Kind
B2
Abstract

Provided are a fluorescent dye and a preparation process and use thereof. The fluorescent dye is able to emit a long wavelength, is sensitive and specific to viscosity, and is used for a wide range of purposes, such as viscosity testing, fluorescent labeling, quantification or detection of proteins, enzymes or nucleic acids. In addition, it can be used as a fluorescent-activated probe.

Claims (52)

1. A fluorescent dye, having a structure represented by formula (I)

wherein,

D- is —OH or N(X 1 )(X 2 )—; X 1 , and X 2 are each independently selected from the group consisting of hydrogen, an alkyl group and a first modified alkyl group; the first modified alkyl group is a group obtained by replacing any carbon atom or any carbon atom with hydrogens thereon of the alkyl group with at least one group selected from the group consisting of a halogen atom, —O—, —OH, —CO—, —CN, —SO 2 —, —(S═O)—, a primary amino group, a secondary amino group, and a tertiary amino group, the first modified alkyl group has 1 to 11 carbon atoms, X 1 and X 2 are optionally linked to each other to form a saturated or unsaturated alicyclic heterocyclic ring; the alicyclic heterocyclic ring is selected from the group consisting of azetidine, pyrrolidine, piperidine, and morpholine;

the ring B is selected from at least one consisting of an aromatic ring and an aromatic heterocyclic ring;

in the structure of the following formula (I-2) formed by condensing the ring B with a thiophene ring, each hydrogen atom contained therein is optionally replaced independently with a substituent selected from the group consisting of an alkyl group and a methoxy group

wherein R 1 is hydrogen;

R 2 is selected from the group consisting of cyano, carboxyl, a keto group, an ester group, an amide group, an aryl group, a heteroaryl group, and a second modified alkyl group; the second modified alkyl group is a group obtained by replacing any carbon atom or any carbon atom with hydrogens thereon of the alkyl group with at least one group selected from the group consisting of —O—, —OH, —CO—, a primary amino group, a secondary amino group, a tertiary amino group, the second modified alkyl group has 1 to 4 carbon atoms; and

R 3 is a cyano group; or

the structural moiety of the following formula (I-3) in the formula (I):

forms a cyclic structure of the following formulae (I-3-a) or (I-3-b):

wherein, R a and R b are selected independently from the group consisting of hydrogen, and an alkyl group;

R c is hydrogen;

R 4 is selected independently from the group consisting of hydrogen, an alkyl group, and an aryl group;

Y 1 is selected from the groups consisting of —O—, —S—, —(S═O)—, and —(NR i )—, wherein R i is selected from the group consisting of hydrogen and an alkyl group;

Y 2 is selected from the group consisting of ═O and ═S; and

Y 3 is selected from the group consisting of ═O and ═S;

wherein,

the alkyl group is a saturated aliphatic linear or branched alkyl group having 1 to 10 carbon atoms;

the aryl group is a five to ten-membered monocyclic or condensed bicyclic ring;

the heteroaryl or the aromatic heterocyclic ring is a five to ten-membered monocyclic or condensed bicyclic ring with at least one heteroatom selected from the group consisting of N, O and S on the ring; and

the halogen atom is each independently selected from the group consisting of F, Cl, Br, and I.

2. The fluorescent dye according to claim 1 , wherein X 1 and X 2 are independently a C 1-10 linear or branched alkyl group optionally substituted by one or more groups selected from the group consisting of hydroxyl and cyano; or a C 2-11 ether chain group having 1 to 10 oxygen atoms and optionally substituted by one or more groups selected from the group consisting of a sulfonic acid group or carboxyl.

3. The fluorescent dye according to claim 1 , wherein the structure of the formula (I-2) is selected from the structures of the following formulae (I-2-1) to (I-2-13), (I-2-16), or (I-2-17):

4. The fluorescent dye according to claim 1 , wherein the R 2 is a group selected from the following structures, or bicyclic or polycyclic condensed aromatic rings or condensed aromatic heterocyclic rings formed by the following structures themselves or condensed therebetween:

5. A fluorescent dye, wherein the fluorescent dye is selected from the group consisting of the compounds of the following formulae:

6. A process for preparing the fluorescent dye according to claim 1 , comprising the step of conducting an aldol condensation reaction of a compound of the formula (II) with a compound of the formula (III):

7. A process comprising using the fluorescent dye according to claim 1 in viscosity testing, fluorescent labeling of a protein, fluorescent labeling of a nucleic acid, quantification or detection of a protein, or quantification or detection of a nucleic acid.

8. A fluorogenic probe, comprising the fluorescent dye according to claim 1 .

9. A process comprising using the fluorogenic probe according to claim 8 in fluorescent labeling of a protein, fluorescent labeling of a nucleic acid, quantification or detection of a protein, or quantification or detection of a nucleic acid.

10. The fluorescent dye according to claim 3 , wherein the R 2 is a group selected from the following structures, or bicyclic or polycyclic condensed aromatic rings or condensed aromatic heterocyclic rings formed by the following structures themselves or condensed therebetween:

11. A process comprising using the fluorescent dye according to claim 4 in viscosity testing, fluorescent labeling of a protein, fluorescent labeling of a nucleic acid, quantification or detection of a protein, or quantification or detection of a nucleic acid.

12. A process comprising using the fluorescent dye according to claim 10 in viscosity testing, fluorescent labeling of a protein, fluorescent labeling of a nucleic acid, quantification or detection of a protein, or quantification or detection of a nucleic acid.

13. A process comprising using the fluorescent dye according to claim 5 in viscosity testing, fluorescent labeling of a protein, fluorescent labeling of a nucleic acid, quantification or detection of a protein, or quantification or detection of a nucleic acid.

14. A fluorogenic probe, comprising the fluorescent dye according to claim 4 .

15. A fluorogenic probe, comprising the fluorescent dye according to claim 10 .

16. A fluorogenic probe, comprising the fluorescent dye according to claim 5 .

17. A process comprising using the fluorogenic probe according to claim 14 in fluorescent labeling of a protein, fluorescent labeling of a nucleic acid, quantification or detection of a protein, or quantification or detection of a nucleic acid.

18. A process comprising using the fluorogenic probe according to claim 15 in fluorescent labeling of a protein, fluorescent labeling of a nucleic acid, quantification or detection of a protein, or quantification or detection of a nucleic acid.

19. A process comprising using the fluorogenic probe according to claim 16 in fluorescent labeling of a protein, fluorescent labeling of a nucleic acid, quantification or detection of a protein, or quantification or detection of a nucleic acid.

20. A fluorescent dye, having a structure represented by formula (I):

wherein,

D- is —OH or N(X 1 )(X 2 )—; X 1 , and X 2 are each independently selected from the group consisting of hydrogen, an alkyl group and a first modified alkyl group; the first modified alkyl group is a group obtained by replacing any carbon atom or any carbon atom with hydrogens thereon of the alkyl group with at least one group selected from the group consisting of a halogen atom, —O—, —OH, —CO—, —CN, —SO 2 —, —(S═O)—, a primary amino group, a secondary amino group, and a tertiary amino group, the first modified alkyl group has 1 to 11 carbon atoms, X 1 and X 2 are optionally linked to each other to form a saturated or unsaturated alicyclic heterocyclic ring; the alicyclic heterocyclic ring is selected from the group consisting of azetidine, pyrrolidine, piperidine, and morpholine;

the ring B is selected from at least one consisting of an aromatic ring and an aromatic heterocyclic ring;

in the structure of the following formula (I-2) formed by condensing the ring B with a thiophene ring, each hydrogen atom contained therein is optionally replaced independently with a substituent selected from the group consisting of an alkyl group and a methoxy group;

the structural moiety of the following formula (I-3) in the formula (I) is one of the following formulae (I-3-1) to (I-3-18):

wherein,

the alkyl group is a saturated aliphatic linear or branched alkyl group having 1 to 10 carbon atoms;

the aryl group is a five to ten-membered monocyclic or condensed bicyclic ring;

the heteroaryl or the aromatic heterocyclic ring is a five to ten-membered monocyclic or condensed bicyclic ring with at least one heteroatom selected from the group consisting of N, O and S on the ring; and

the halogen atom is each independently selected from the group consisting of F, Cl, Br, and I.

21. The fluorescent dye according to claim 20 , wherein X 1 and X 2 are independently a C 1-10 linear or branched alkyl group optionally substituted by one or more groups selected from the group consisting of hydroxyl and cyano; or a C 2-11 ether chain group having 1 to 10 oxygen atoms and optionally substituted by one or more groups selected from the group consisting of a sulfonic acid group and carboxyl.

22. The fluorescent dye according to claim 20 , wherein the structure of the formula (I-2) is selected from the structures of the following formulae (I-2-1) to (I-2-13), (I-2-16), and (I-2-17):

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2021
From: SHANGHAI GLORY CAPITAL MANAGEMENT, LTD.
To: FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY LTD.
Reel/Frame 055095/0920 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2020
From: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
To: SHANGHAI GLORY CAPITAL MANAGEMENT., LTD.
Reel/Frame 052795/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2019
From: ZHU, LINYONG; YANG, YI; ZHANG, DASHENG; DU, ZENGMIN; BAO, BINGKUN; LIN, QIUNING; LI, YAN; CHEN, XIANJUN; YANG, LIPENG; BAO, CHUNYAN
To: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
Reel/Frame 048056/0815 →
Priority Claims (1)
CN 201610573970.X · Jul 20, 2016 · national
Continuity (1)
Related Publication 20190241584A1 · Aug 8, 2019